$38.120
+0.061 (+0.16%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
NVO Prediction & Forecast by Similar Chart Analysis
Alphio's NVO stock price prediction model matches the current Novo Nordisk A/S tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $37.69 (-1.12%). The 1-week path is $37.85 (-0.70%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Novo Nordisk A/S Stock?
Novo Nordisk is currently a hold. The stock is trading at $38.64, which is below the analyst price target of $40 from Morgan Stanley, indicating limited upside. Additionally, the forward P/E ratio is 11.83, suggesting it may be undervalued, but the company faces significant competition from Eli Lilly, which could impact future growth.
NVO stock price ended at $38.12 on Wednesday, after rising +0.16%
Novo Nordisk A/S (NVO) last closed at $38.12, gaining +0.16%. These facts feed the 1-day and 1-week NVO price prediction above.
Analyst Consensus
Novo Nordisk A/S (NVO): 0 buy, 1 hold, 0 sell. Outlook: Hold.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Novo Nordisk A/S (NVO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches NVO, ranked by similarity.
Seasonality analysis for NVO
Historically the probability of a positive October return for NVO is 40.35%. January offers the highest probability of a positive month at 67.21%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for NVO
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $80.81 | $91.03 | $96.90 | +138.79% |
| Nov 2026 | $83.51 | $89.42 | $100.21 | +134.58% |
| Dec 2026 | $73.30 | $84.65 | $87.35 | +122.07% |
In 2026, Novo Nordisk A/S (NVO) is projected to range from $73.30 to $100.21.
Novo Nordisk A/S 2026 monthly forecast
In Oct 2026, Novo Nordisk A/S is projected to average $91.03, with a low of $80.81 and high of $96.90.
In Nov 2026, Novo Nordisk A/S is projected to average $89.42, with a low of $83.51 and high of $100.21.
In Dec 2026, Novo Nordisk A/S is projected to average $84.65, with a low of $73.30 and high of $87.35.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.